Future FDA-approved access: If approval happens, the pricing model will likely shift again toward branded pricing, insurance rules, copays, prior authorization, and retail or specialty pharmacy dispensing
Sorry, not sorry for the pun, but this should NOT be one size fits all, and the objective of #obesitydrugdevelopment should NOT merely be the most weight loss as fast as possible for everyone and the same dose for both wt loss and wt maintenance
It takes five seconds
Gallbladder-related events, including cholelithiasis (gallstones) and cholecystitis, were reported in a small number of participants receiving active treatment a finding consistent with the known class effect of GLP-1 receptor agonists
This single equipment choice, often at minimal additional cost per syringe, meaningfully extends how far your medication supply goes
Explore Microdosing GLP-1 options here or chat with your Alan Health provider to learn whether microdosing is right for you directly in your portal
